ITGA6 and metastatic neoplasm: To investigate the potential role of ITGA6 as a biomarker in the early diagnosis of HCC, scRNA-seq data of patient tissues from primary and metastatic tumors, GSE149614 was employed, and cell-specific expression levels in peritumoral non-cancerous and liver cancer tissues were measured [16].